find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
298
Clinical Trials
Phase 1 Clinical Trials
Phase I
Active
Phase 1 Clinical Trials
Phase I
Active
nct/study# NA / P153CV-RAS-001
Phase I Study Dose Finding Study To Evaluate Safety, Reactogenicity And Immunogenicity Of CV09040102 RAS G12D Mrna Vaccine In HLA- Selected Patients With Pancreatic Cancer Or Colorectal Cancer Harboring The RAS G12D Mutation
Learn More
Phase 1 Clinical Trials
Phase I
Active
nct/study# NA / TAB006-01
A Phase 1, Multicenter, Open-Label Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Preliminary Efficacy Of TAB006, As Monotherapy And In Combination With Toripalimab, In Patients With Previously Treated, Advanced Malignancies
Learn More
Phase 1 Clinical Trials
Phase I/II
Active
nct/study# NA / BND-22-001
?A Phase 1/2, Dose Escalation And Expansion Study Of The Safety, Tolerability, And Anti-Tumor Activity Of BND-22 Administered Alone And In Combination With Pembrolizumab Or With Cetuximab In Patients With Advanced Solid Tumors
Learn More
Phase 1 Clinical Trials
NA
Active
nct/study# NA / CDA-LB-139-TNFR2-BITT
The Effects And Mechanisms Of TNF-α/TNFR2 In Regulatory T Cells On Microenvironment And Progression In Gastric Cancer
Learn More
Phase 1 Clinical Trials
Phae Ia/1b
Active
nct/study# NA / PY314-1-01
A Phase 1a/1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PY314 as a Single Agent and In Combination with Pembrolizumab in Subjects with Advanced Solid Tumors
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.